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Scopo




Low molecular-weight Gd-chelates are widely used in clinical MRI for various purposes. However, these contrast agents (CAs) have several
shortcomings: they rapidly extravasate from blood vessels to the interstitial space, have a short circulation times and show poor contrast
at high magnetic fields. Incorporating gadolinium into flexible nanogels has the potential of increasing intravascular half-life, accumulation
and retention in specific body compartments of the CA as well as increasing the MR signal, since many metal ions can be coordinated to
the same nanoparticle.
Risultati
Biocompatible, “as born” sterile nanogels have been produced with high yields and through-puts by pulsed e-beam irradiation of aqueous
solutions of poly(N-vinyl pyrrolidone) and acrylates, using industrial accelerators. The nanogels have been fully characterized for their
structural and physico-chemical properties and decorated with peptides or antibodies. Diethylenetriamine pentaacetic (DTPA) chelating
moieties have been covalently bound to the nanogels.
Conclusioni
The produced nanogels have controlled size in the nanoscale range (from 20 to 100 nm), good colloidal stability in physiological conditions
and a large number of accessible reactive groups for multiple attachment of targeting agents and/or bio-active compounds for therapeutic
purposes. Formation of stable Gd3+ complexes is demonstrated. These nanogels are being further engineered towards multi-modality
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